MedPath

大同市利群药业有限责任公司

Ownership
-
Established
2004-12-13
Employees
-
Market Cap
-
Website
http://www.dtlqyy.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

133

NMPA:133

Drug Approvals

Guaifenesin Tablets

Product Name
愈创甘油醚片
Approval Number
国药准字H14022723
Approval Date
Aug 31, 2020
NMPA

Vitamin B6 Tablets

Product Name
维生素B6片
Approval Number
国药准字H14020230
Approval Date
Aug 31, 2020
NMPA

Pediatric Paracetamol, Aminophenazone,Caffeine and Chlorphenamine Maleate Granules

Product Name
小儿酚氨咖敏颗粒
Approval Number
国药准字H14023283
Approval Date
Aug 31, 2020
NMPA

Indometacin Enteric-coated Tablets

Product Name
吲哚美辛肠溶片
Approval Number
国药准字H14020511
Approval Date
Aug 31, 2020
NMPA

Furosemide Tablets

Product Name
呋塞米片
Approval Number
国药准字H14020358
Approval Date
Aug 31, 2020
NMPA

Nefopam Hydrochloride Tablets

Product Name
盐酸奈福泮片
Approval Number
国药准字H14020836
Approval Date
Aug 31, 2020
NMPA

复方茶碱麻黄碱片

Approval Number
国药准字H14023666
Approval Date
Aug 31, 2020
NMPA

Moroxydine Hydrochloride Tablets

Product Name
盐酸吗啉胍片
Approval Number
国药准字H14022754
Approval Date
Aug 31, 2020
NMPA

Doxycycline Hyclate Tablets

Product Name
盐酸多西环素片
Approval Number
国药准字H14020498
Approval Date
Aug 31, 2020
NMPA

Aspirin Enteric-coated Tablets

Product Name
阿司匹林肠溶片
Approval Number
国药准字H14022743
Approval Date
Aug 31, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 14
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.